🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Survey on Epidemiology of Hypoparathyroidism in France

Recruitingn/aAges any - anyAllEuropean Georges Pompidou Hospital
NCT02838927 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Very few data has been published on the epidemiology of hypoparathyroidism worldwide: none exists specifically for France. Hypoparathyroidism could led to complications. Here, the investigators plan to collect data about both epidemiology, medication and complication of hypoparathyroidism in France.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * patient fro whom chronic hypoparathyroidism is diagnosed * patient living in France Exclusion Criteria: * patient who does not want his data to be collected in this registry * pseudo-hypoparathyroidism * acute hypoparathyroidism
💊

What it tests

  • No intervention
📍

Where

57 sites
Felix Guyon Hospital
Saint-Denis, France
Hôpital Privé de Provence
Aix-en-Provence, France
Amiens University Hospital
Amiens, France
Clinic Auch Area
Auch, France
Henri Mondor Hospital
Aurillac, France
Jean Minjoz Hospital
Besançon, France
Blanquefort
Blanquefort, France
Avicenne Hospital, AP-HP
Bobigny, France

…and 49 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy